Surprisingly, pneumonitis was more common in those with ER/PR negative with low HER2 and low HER2 expression, suggesting off-target delivery of the deruxtecan payload may contribute to the risk for pneumonitis. The gene discussed is ERBB2; the disease is pneumonitis.